Drugs / EC17
EC17
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT01778933 | May 2013 → Sep 2014 | renal cell carcinoma | University of Pennsylvania | Completed | No outcome recorded |
| Phase 14 trials | ||||||
| Phase 1 | NCT01994369 | May → Nov 2014 | female breast carcinoma | University of Pennsylvania | Completed | No outcome recorded |
| Phase 1 | NCT02000778 | Nov 2013 → Nov 2014 | ovarian carcinoma | University of Pennsylvania | Completed | No outcome recorded |
| Phase 1 | NCT01996072 | Nov 2013 → Sep 2014 | primary hyperparathyroidism | University of Pennsylvania | Completed | No outcome recorded |
| Phase 1 | NCT00329368 | Sep 2005 → Dec 2007 | cancer | Endocyte | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01511055 | Jan 2012 → Jun 2014 | ovarian carcinoma | Mayo Clinic | Terminated | No outcome recorded |
| Phase 2 | NCT00485563 | Jun 2007 → Aug 2008 | renal cell carcinoma | Endocyte | Terminated | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC-17 | “Folate-fluorescein isothiocyanate, or folate-FITC, also identified as EC-17, targets folate receptors over expressed in certain cancers such as breast cancer, and could help in...” NCT01994369 ↗7“The group will receive a single dose of EC17, infused over 10 minutes, prior to surgery. Then, during surgery, the EC-17 will be imaged with a camera that the investigators...” NCT01996072 ↗ |
| Known as | EC17 (Folate-FITC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00329368 ↗ |
| Known as | Folate-FITC | “A fluorescent contrast agent (folate-FITC or EC17) will be used to determine if it will localize to the primary tumor nodule(s) or mass(es) of patients undergoing parathyroid surgery.” NCT01996072 ↗1“EC17 (Folate-FITC)” NCT00485563 ↗ |
| Known as | Folate-fluorescein conjugate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297279 ↗ |
| Action | Deplete | “mark it for destruction by the body's immune system” NCT00329368 ↗ |
| Modality | Other / unclassified | “a drug made by linking folate (a vitamin) with FITC” NCT00485563 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT00329368 ↗ |